STARS Webinar - Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials-Traducción de audio al español

Video Transcription

Video Summary

The webinar titled "Finding the right dose using patient-reported data from early-phase clinical trials" discussed the importance of patient-reported data in determining the optimal dosage for cancer treatments. The webinar highlighted the patient-centered dosing initiative and its mission to mitigate the prevalence and severity of treatment-related side effects in patients with metastatic breast cancer. The initiative conducted surveys among patients and oncologists to understand the prevalence of side effects, the level of communication between doctors and patients, and the impact of lower doses on patient outcomes. The surveys revealed that patients experienced a considerable number of side effects, many of which were not accurately reported by their doctors. Both patients and doctors expressed a willingness to discuss flexible dosing options based on patient characteristics. The webinar also touched on the FDA's efforts in this area, such as the Optimus project and the Renewal project, which aim to optimize cancer treatments and review the dosages of certain approved cancer drugs. The speakers emphasized the importance of patient involvement in research protocols, advocacy work, and the measurement of tolerability from the patient's perspective. Overall, the webinar highlighted how patient-reported data can play a crucial role in finding the right dosage and improving treatment outcomes for cancer patients.

Asset Subtitle

(Spanish Audio Translation)

Meta Tag

Concept Maximum Tolerated Dose

Concept Dose Selection

Concept Longitudinal Patient-Reported Outcome

Concept Patient-Centered Dosing Initiative

Concept Dose Escalation

Keywords

Finding the right dose

Patient-reported data

Early-phase clinical trials

Cancer treatments

Patient-centered dosing initiative

Metastatic breast cancer

Treatment-related side effects

Surveys

Flexible dosing options

FDA's efforts

Maximum Tolerated Dose

Dose Selection

Longitudinal Patient-Reported Outcome

Patient-Centered Dosing Initiative

Dose Escalation